R Kuehl1, S Tschudin-Sutter1, M Morgenstern2, M Dangel1, A Egli3, A Nowakowski2, N Suhm2, C Theilacker1, A F Widmer4. 1. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland. 2. Orthopaedic and Traumatological Department, University Hospital Basel, Switzerland. 3. Division of Clinical Microbiology, University Hospital Basel, Switzerland; Applied Microbiology Research, Department Biomedicine, University of Basel, Switzerland. 4. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland. Electronic address: andreas.widmer@usb.ch.
Abstract
OBJECTIVES: Little information has been published on orthopaedic internal fixation-associated infections. We aimed to analyse time-dependent microbiology, treatment, and outcome. METHODS: Over a 10-year period, all consecutive patients with internal fixation-associated infections at the University Hospital of Basel, were prospectively followed and clinical, microbiological and outcome data were acquired. Infections were classified as early (0-2 weeks after implantation), delayed (3-10 weeks), and late (>10 weeks). RESULTS: Two hundred and twenty-nine patients were included, with a median follow-up of 773 days (IQR 334-1400). Staphylococcus aureus was the most prevalent pathogen (in 96/229 patients, 41.9%). Enterobacteriaceae were frequent in early infections (13/49, 26.5%), whereas coagulase-negative staphylococci (36/92, 39.1%), anaerobes (15/92, 16.3%) and streptococci (10/92, 10.9%) increased in late revisions. Failure was observed in 27/229 (11.7%). Implants were retained in 42/49 (85.7%) in early, in 51/88 (57.9%) in delayed, and in 9/92 (9.8%) in late revisions (p < 0.01). Early revisions failed in 6/49 (12.2%), delayed in 9/88 (10.2%), and late in 11/92 (13.0%) (p 0.81). Debridement and retention failed in 6/42 (14.3%) for early, in 6/51 (11.8%) for delayed, and in 3/9 (33.3%) for late revisions (p 0.21). Biofilm-active antibiotic therapy tailored to resistance correlated with improved outcome for late revisions failure (6/72, 7.7% versus 6/12, 50.0%; p < 0.01) but not for early revisions failure (5/38, 13.2% versus 1/11, 9.1%; p 1.0). CONCLUSIONS: Treatment of internal fixation-associated infections showed a high success rate of 87-90% over all time periods. Implant retention was highly successful in early and delayed infections but only limited in late infections.
OBJECTIVES: Little information has been published on orthopaedic internal fixation-associated infections. We aimed to analyse time-dependent microbiology, treatment, and outcome. METHODS: Over a 10-year period, all consecutive patients with internal fixation-associated infections at the University Hospital of Basel, were prospectively followed and clinical, microbiological and outcome data were acquired. Infections were classified as early (0-2 weeks after implantation), delayed (3-10 weeks), and late (>10 weeks). RESULTS: Two hundred and twenty-nine patients were included, with a median follow-up of 773 days (IQR 334-1400). Staphylococcus aureus was the most prevalent pathogen (in 96/229 patients, 41.9%). Enterobacteriaceae were frequent in early infections (13/49, 26.5%), whereas coagulase-negative staphylococci (36/92, 39.1%), anaerobes (15/92, 16.3%) and streptococci (10/92, 10.9%) increased in late revisions. Failure was observed in 27/229 (11.7%). Implants were retained in 42/49 (85.7%) in early, in 51/88 (57.9%) in delayed, and in 9/92 (9.8%) in late revisions (p < 0.01). Early revisions failed in 6/49 (12.2%), delayed in 9/88 (10.2%), and late in 11/92 (13.0%) (p 0.81). Debridement and retention failed in 6/42 (14.3%) for early, in 6/51 (11.8%) for delayed, and in 3/9 (33.3%) for late revisions (p 0.21). Biofilm-active antibiotic therapy tailored to resistance correlated with improved outcome for late revisions failure (6/72, 7.7% versus 6/12, 50.0%; p < 0.01) but not for early revisions failure (5/38, 13.2% versus 1/11, 9.1%; p 1.0). CONCLUSIONS: Treatment of internal fixation-associated infections showed a high success rate of 87-90% over all time periods. Implant retention was highly successful in early and delayed infections but only limited in late infections.
Authors: T Fintan Moriarty; Willem-Jan Metsemakers; Mario Morgenstern; Marloes I Hofstee; Alejandro Vallejo Diaz; James E Cassat; Britt Wildemann; Melissa Depypere; Edward M Schwarz; R Geoff Richards Journal: Nat Rev Dis Primers Date: 2022-10-20 Impact factor: 65.038
Authors: Thomas K Fehring; Keith A Fehring; Angela Hewlett; Carlos A Higuera; Jesse E Otero; Aaron J Tande Journal: J Bone Joint Surg Am Date: 2020-07-15 Impact factor: 6.558
Authors: Melissa Depypere; Richard Kuehl; Willem-Jan Metsemakers; Eric Senneville; Martin A McNally; William T Obremskey; Werner Zimmerli; Bridget L Atkins; Andrej Trampuz Journal: J Orthop Trauma Date: 2020-01 Impact factor: 2.884
Authors: Madeleine C Stevenson; Julia C Slater; H Claude Sagi; Federico Palacio Bedoya; Margaret V Powers-Fletcher Journal: J Clin Microbiol Date: 2021-06-16 Impact factor: 11.677
Authors: Willem-Jan Metsemakers; Mario Morgenstern; Eric Senneville; Olivier Borens; Geertje A M Govaert; Jolien Onsea; Melissa Depypere; R Geoff Richards; Andrej Trampuz; Michael H J Verhofstad; Stephen L Kates; Michael Raschke; Martin A McNally; William T Obremskey Journal: Arch Orthop Trauma Surg Date: 2019-10-29 Impact factor: 3.067
Authors: Mario Morgenstern; Christoph Erichsen; Matthias Militz; Zhao Xie; Jiachen Peng; James Stannard; Willem-Jan Metsemakers; Dirk Schaefer; Volker Alt; Kjeld Søballe; Michael Nerlich; Richard E Buckley; Michael Blauth; Michael Suk; Frankie Leung; Jorge D Barla; Kiminori Yukata; Bi Qing; Stephen L Kates Journal: J Orthop Res Date: 2020-07-27 Impact factor: 3.102